{"id":1048041,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-11","captureTimestamp":"2026-03-11T14:13:06.890000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis: A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Summary SGLT2 inhibitor use was associated with an increased risk of DKA compared to DPP-4 inhibitors among patients with…","rawSnapshotUrl":"/api/snapshots/raw/1048041","browseUrl":"https://replay.healtharchive.ca/job-8/20260311141306/https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true#ha_snapshot=1048041","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}